This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
HBSP (USA)
-
Identificación de la estructura de capital de una firma (Spanish Version)
Becker, BoCase HBS-212S08FinanceSe les pide a los estudiantes a relacionar los balances ocultas con las descripciones firmes. El caso ayuda a los estudiantes a entender cómo los balances reflejan la industria y características de la empresa.Starting at €8.20
-
Brighter Smiles for the Masses--Colgate vs. P&G (Spanish version)
Oberholzer-Gee, Felix; Yao, Dennis; Azevedo Jorge, FilipaCase HBS-707S33StrategyIn 2000, Procter & Gamble Co. introduced Crest Whitestrips, a new, revolutionary product that allowed consumers to whiten their teeth at home. With Whitestrips, P&G created an entire new category in oral care, worth $460 million in 2002. Whitestrips sent P&G's main competitor in oral care, Colgate Palmolive Co., scrambling because several patents protected the strips, making it difficult for Colgate to copy the invention. But in September 2002, t...Starting at €8.20
-
Launching Prius (Spanish version)
Reinhardt, Forest L.; Yao, Dennis; Egawa, MasakoCase HBS-712S03StrategyIn 1995, Hiroshi Okuda, president of Toyota Motor Corp., considers whether to push for a more aggressive launch of the Toyota Prius--an automobile that incorporates Toyota's new and technically advanced hybrid power train. This launch decision allows discussion of the importance of the Prius in Toyota's overall product strategy and explores issues ranging from market structure to competitive advantage and competitive dynamics.Starting at €8.20
-
Roche's Acquisition of Genentech
Baldwin, Carliss Y.; Becker, Bo; Dessain, VincentCase HBS-210040-EFinanceFranz Humer, CEO of the Roche Group, must decide whether to mount a hostile tender offer for the publicly-owned shares of Roche's biotechnology subsidiary, Genentech. The case provides opportunities to analyze Roche's strategy with respect to Genentech, tStarting at €8.20
-
Kroll Bond Rating Agency
Becker, BoCase HBS-212034-EFinanceThe established credit raters were criticized for inflating the mortgage credit bubble that imploded in 2008. A new rating agency, KBRA, is considering how to capitalize on the opportunity this presents and how to enter the industry. A small group of managers have to decide on a business model, how to meet hiring and funding needs, and what types of ratings to start with: municipal, corporate, or structured. Where are the needs for new ratings st...Starting at €8.20
-
L'Occitane en Provence
Becker, Bo; Beyersdorfer, Daniela; Mayfield, E. Scott; Yamazaki, MayukaCase HBS-212051-EFinanceCosmetics company L'Occitane en Provence must decide if it is the right time to go public, and, if so, where to list. The firm could list on Euronext in Paris, close to the firm's headquarters in southern France, on one of the large exchanges in the United States, or perhaps in Asia, where much of the firm's future growth is expected. The case provides opportunities to discuss the benefits and costs of going public, including valuation implicatio...Starting at €8.20
-
Preem (A)
Becker, Bo; Lobb, Annelena; Sesia, AldoCase HBS-213008-EFinanceHigh yield bond fund Proventus Capital Partners (PCP) has invested in underwater bonds issued by Preem, a large oil refinery. As maturity approaches, in the midst of a financial crisis, Preem appears unlikely to be able to refinance. Meanwhile, Preem has a complicated multi-currency capital structure with senior, secured bank loans and junior bonds. PCP has to decide whether to push for bankruptcy in a European court, or for out of court renegoti...Starting at €8.20
-
Preem (A) and (B), Teaching Note
Becker, BoTeaching Note HBS-213015-EFinanceTeaching Note for 213008 and 213014Starting at €0.00
-
L'Occitane en Provence, Teaching Note
Becker, Bo; Mayfield, E. ScottTeaching Note HBS-213037-EFinanceTeaching Note for 212051Starting at €0.00
-
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug, Teaching Note
Oberholzer-Gee, Felix; Yao, DennisTeaching Note HBS-707542-EStrategyTeaching note to 706454.Starting at €0.00